Contents of this document
- Increase in revenue¥155 million
- Increase in gross profit¥43 million
- Decrease in SG&A expenses¥80 million
- Increase in operating profit¥124 million
- Launch of the new medium-term management plan, VISION 30S
- Begin sales of CC for coliform detection under aS-Medium, a new hygiene testing product
- Full-year sales volume (semiconductor materials)6,653 10,000 mYear on year against the same period last yearup 5.9% year on year
- EBITDA¥416 millionYear on year against the same period last yearup from ¥338 million in the previous fiscal year
- Equity ratio38.9 %Year on year against the same period last yearup from 36.6% in the previous fiscal year
- Semiconductor materialsNet SalesFiscal year ending March 2025 ¥1,136 million / Fiscal year ending March 2026 ¥1,165 million / yoy_pct ¥2.6 millionGross profitFiscal year ending March 2025 ¥445 million / Fiscal year ending March 2026 ¥451 millionOperating profitFiscal year ending March 2025 ¥84 million / Fiscal year ending March 2026 ¥102 million / yoy_pct ¥21.3 million
- Hygiene testing materialsNet SalesFiscal year ending March 2025 ¥1,840 million / Fiscal year ending March 2026 ¥1,928 million / yoy_pct ¥4.8 millionGross profitFiscal year ending March 2025 ¥808 million / Fiscal year ending March 2026 ¥891 millionOperating profitFiscal year ending March 2025 ¥134 million / Fiscal year ending March 2026 ¥232 million / yoy_pct ¥72.5 million
- PIMNet SalesFiscal year ending March 2025 ¥213 million / Fiscal year ending March 2026 ¥263 million / yoy_pct ¥23.3 millionGross profitFiscal year ending March 2025 ¥23 million / Fiscal year ending March 2026 ¥-11 millionOperating profitFiscal year ending March 2025 ¥-145 million / Fiscal year ending March 2026 ¥-129 million / Change in amount ¥15 million
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | Fiscal year ended March 2026 (57th fiscal year) |
| Net Sales | ¥3,357 million (YoY +4.9%) |
| Operating profit | ¥204 million (YoY +154.0%) |
| Ordinary income | ¥209 million (YoY +223.6%) |
| Net income | ¥141 million (net income attributable to owners of the parent) (YoY +252.4%) |
| Gross profit | ¥1,332 million, gross margin of 39.7%, down 0.5 percentage points year on year |
| Operating profit margin | 6.1%, up 3.6 percentage points year on year |
| Selling, general and administrative expenses | ¥1,127 million |
| Full-year earnings forecast | Fiscal Period Covered Fiscal year ending March 2027 / Net Sales ¥3,600 million / Operating profit ¥210 million / Ordinary income ¥200 million / Net income ¥120 million (net income attributable to owners of the parent) / Dividend Forecast ¥10 |
| Segment results | Segment Semiconductor materials / Net Sales Fiscal year ending March 2025 ¥1,136 million / Fiscal year ending March 2026 ¥1,165 million / yoy_pct ¥2.6 million / Gross profit Fiscal year ending March 2025 ¥445 million / Fiscal year ending March 2026 ¥451 million / Operating profit Fiscal year ending March 2025 ¥84 million / Fiscal year ending March 2026 ¥102 million / yoy_pct ¥21.3 million, Segment Hygiene testing materials / Net Sales Fiscal year ending March 2025 ¥1,840 million / Fiscal year ending March 2026 ¥1,928 million / yoy_pct ¥4.8 million / Gross profit Fiscal year ending March 2025 ¥808 million / Fiscal year ending March 2026 ¥891 million / Operating profit Fiscal year ending March 2025 ¥134 million / Fiscal year ending March 2026 ¥232 million / yoy_pct ¥72.5 million, Segment PIM / Net Sales Fiscal year ending March 2025 ¥213 million / Fiscal year ending March 2026 ¥263 million / yoy_pct ¥23.3 million / Gross profit Fiscal year ending March 2025 ¥23 million / Fiscal year ending March 2026 ¥-11 million / Operating profit Fiscal year ending March 2025 ¥-145 million / Fiscal year ending March 2026 ¥-129 million / Change in amount ¥15 million |
| Breakdown of Factors Affecting the Change | Factors Increase in revenue / Amount ¥155 million, Factors Increase in gross profit / Amount ¥43 million, Factors Decrease in SG&A expenses / Amount ¥80 million, Factors Increase in operating profit / Amount ¥124 million |
| Key KPIs | Indicator name Full-year sales volume (semiconductor materials) / Value 6,653 10,000 m / Year on year against the same period last year up 5.9% year on year, Indicator name EBITDA / Value ¥416 million / Year on year against the same period last year up from ¥338 million in the previous fiscal year, Indicator name Equity ratio / Value 38.9 % / Year on year against the same period last year up from 36.6% in the previous fiscal year |
| Unit price and quantity metrics | Full-year sales volume of semiconductor materials was 66.53 million m, up 5.9% year on year. The breakdown between unit price and volume is not disclosed |
| Assumptions Underlying the Business Outlook | Raw material, energy and labor costs are expected to remain elevated. Trends in the situation in the Middle East and raw material and auxiliary material prices remain uncertain. Numerical assumptions are not disclosed |
| Medium-term management plan targets | The presentation only states that the fiscal year ending March 2027 is the first year of the new medium-term management plan, VISION 30S. Target figures and target years are not disclosed |
| Financial targets | The actual equity ratio of 38.9% is stated. Target figures for ROE, ROIC, the D/E ratio and other metrics are not disclosed |
| Annual Dividend | The dividend forecast for the fiscal year ending March 2027 is ¥10 per share. The interim and year-end breakdown is not disclosed |
| New initiatives | Launch of the new medium-term management plan, VISION 30S, Begin sales of CC for coliform detection under aS-Medium, a new hygiene testing product |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company cites higher profit from increased revenue, appropriate pricing, higher gross profit, and lower depreciation and amortization, recruitment costs, overtime costs and other expenses as reasons for the increase in operating profit. At the same time, it expects raw material and energy costs and labor costs to remain elevated, while uncertainty over the situation in the Middle East continues.